Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro

被引:80
作者
Ciechanowicz, S. [1 ]
Zhao, H. [1 ]
Chen, Q. [1 ,2 ]
Cui, J. [1 ]
Mi, E. [1 ]
Mi, E. [1 ]
Lian, Q. [3 ]
Ma, D. [1 ]
机构
[1] Imperial Coll London, Chelsea & Westminster Hosp, Fac Med, Dept Surg & Canc Anaesthet Pain Med & Intens Care, London, England
[2] Third Mil Med Univ, Southwest Hosp, Dept Anesthesiol, Chongqing, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China
关键词
anaesthetic drugs; carcinoma; kidney; lung; metastasis; SIGNALING PATHWAY; CANCER CELLS; GROWTH; EXPRESSION; APOPTOSIS; INVASION; INJURY;
D O I
10.1016/j.bja.2017.11.066
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Increasing evidence suggests that perioperative factors including anaesthetics influence cancer recurrence and metastasis after surgery. This study investigated the influence of sevoflurane on the response of lung and renal cancer cells to cisplatin, with focus on transforming growth factor-beta (TGF-beta) and osteopontin (OPN) that are both closely associated with cancer tumorigenesis and metastasis. Methods: Non-small cell lung adenocarcinoma (A549) and renal cell carcinoma (RCC4) cells were exposed to 3.6% sevoflurane for two hrs. Malignant potential represented by cell viability, migration, chemosensitivity to cisplatin was evaluated. Expression of OPN, TGF-beta 1, TGF-beta receptor type II (TGF-beta RII) and the canonical downstream effector Smad3 was assessed. SiRNA knockdown of TGF-beta 1 and OPN and chemical inhibition of TGF-beta RI/II was performed. Results: Sevoflurane reduced cell viability (0.394) versus control (0.459) (P < 0.01), enhanced chemosensitivity but had no effect on migration of A549 cells. It enhanced viability (0.467) versus control (0.347) (P < 0.001), chemoresistance and migration of RCC4. In A549, there was enhanced nuclear Smad3. In RCC4, TGF-beta RII and OPN were upregulated, while TGF-beta 1 was over-expressed with reduced nuclear Smad3. TGF-beta RII inhibition and OPN knockdown abolished sevoflurane-mediated viability, and migration, respectively, in RCC4. Conclusions: Sevoflurane promotes the metastatic potential of renal carcinoma, but not of non-small cell lung cancer. This may be associated with its differential effect on cellular signalling including TGF-beta. Our findings indicate that sevoflurane may have different effects on the metastatic potential and chemosensitivity of different tumour types.
引用
收藏
页码:368 / 375
页数:8
相关论文
共 27 条
[1]   Isoflurane, a Commonly Used Volatile Anesthetic, Enhances Renal Cancer Growth and Malignant Potential via the Hypoxia-inducible Factor Cellular Signaling Pathway In Vitro [J].
Benzonana, Laura L. ;
Perry, Nicholas J. S. ;
Watts, Helena R. ;
Yang, Bob ;
Perry, Iain A. ;
Coombes, Charles ;
Takata, Masao ;
Ma, Daqing .
ANESTHESIOLOGY, 2013, 119 (03) :593-605
[2]   Genotoxicity and Cytotoxicity of Cisplatin Treatment Combined with Anaesthetics on EAT Cells In Vivo [J].
Brozovic, Gordana ;
Orsolic, Nada ;
Knezevic, Fabijan ;
Knezevic, Anica Horvat ;
Benkovic, Vesna ;
Sakic, Katarina ;
Hrgovic, Zlatko ;
Bendelja, Kreso ;
Fassbender, Walter J. .
ONKOLOGIE, 2009, 32 (06) :337-343
[3]   Special issue on anaesthesia and cancer [J].
Buggy, D. J. ;
Hemmings, H. C. .
BRITISH JOURNAL OF ANAESTHESIA, 2014, 113 :1-3
[4]  
Cardillo MR, 2001, ANAL QUANT CYTOL, V23, P109
[5]  
Ecimovic P, 2013, ANTICANCER RES, V33, P4255
[6]   Transforming Growth Factor β Signaling Overcomes Dasatinib Resistance in Lung Cancer [J].
Gordian, Edna ;
Li, Jiannong ;
Pevzner, Yuri ;
Mediavilla-Varela, Melanie ;
Luddy, Kimberly ;
Ohaegbulam, Kim ;
Daniel, Kenyon G. ;
Haura, Eric B. ;
Munoz-Antonia, Teresita .
PLOS ONE, 2014, 9 (12)
[7]   Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin [J].
Han, Juying ;
Zhang, Fuming ;
Xie, Jin ;
Linhardt, Robert J. ;
Hiebert, Linda M. .
CARDIOVASCULAR DIABETOLOGY, 2009, 8 :46
[8]   Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells [J].
Iwasaki, Masae ;
Zhao, Hailin ;
Jaffer, Tanweer ;
Unwith, Sandeep ;
Benzonana, Laura ;
Lian, Qingquan ;
Sakamoto, Atsuhiro ;
Ma, Daqing .
ONCOTARGET, 2016, 7 (18) :26042-26056
[9]   miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC [J].
Jingushi, Kentaro ;
Ueda, Yuko ;
Kitae, Kaori ;
Hase, Hiroaki ;
Egawa, Hiroshi ;
Ohshio, Ikumi ;
Kawakami, Ryoji ;
Kashiwagi, Yuri ;
Tsukada, Yohei ;
Kobayashi, Takumi ;
Nakata, Wataru ;
Fujita, Kazutoshi ;
Uemura, Motohide ;
Nonomura, Norio ;
Tsujikawa, Kazutake .
MOLECULAR CANCER RESEARCH, 2015, 13 (03) :565-574
[10]  
Kawaraguchi Y, 2014, FASEB J, P28